1. Home
  2. FRSH vs TYRA Comparison

FRSH vs TYRA Comparison

Compare FRSH & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$9.34

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$26.76

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
TYRA
Founded
2010
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
FRSH
TYRA
Price
$9.34
$26.76
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$14.86
$47.50
AVG Volume (30 Days)
12.0M
825.8K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
296.88
N/A
EPS
N/A
N/A
Revenue
$838,809,000.00
N/A
Revenue This Year
$16.30
N/A
Revenue Next Year
$14.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.43
N/A
52 Week Low
$6.79
$8.98
52 Week High
$15.51
$40.65

Technical Indicators

Market Signals
Indicator
FRSH
TYRA
Relative Strength Index (RSI) 52.15 34.51
Support Level $7.71 $24.88
Resistance Level $9.40 $31.57
Average True Range (ATR) 0.43 1.93
MACD -0.06 -0.41
Stochastic Oscillator 22.16 22.97

Price Performance

Historical Comparison
FRSH
TYRA

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: